The Shrinking UK Pharmacy Network: 1,200+ Closures Since 2017

In 2016 the UK had approximately 14,200 community pharmacies. Today our directory holds around 13,000 active records across England, Scotland, Wales and Northern Ireland. Roughly one in twelve UK community pharmacies has closed its doors in a decade, and the headline figure of a 1,200-pharmacy net loss is now broadly accepted by Community Pharmacy England, the BBC and the Pharmaceutical Journal.

The reasons are economic, demographic and political: a real-terms cut to NHS contract funding, margin compression on generic dispensing, a wave of chain restructures (most notably Lloyds Pharmacy’s exit from the UK market in 2023 to 2024), and a generational succession crisis among independent owners. This article unpacks each driver, looks at the geographic pattern of closures, and asks what the 2026 to 2028 contractual framework negotiations mean for the network that survives.

The headline numbers

The single most authoritative public source for the contraction story is Community Pharmacy England’s Pharmacy Pressures Survey and its annual state-of-pharmacy reporting. CPE has repeatedly reported a net loss of approximately 1,200 community pharmacies in England between 2017 and 2024. Our directory snapshot, taken from the live Find a Pharmacy database in May 2026, breaks down as follows:

• England: 10,508 active pharmacies (vs roughly 11,800 in 2017)
• Scotland: 1,283 active (vs roughly 1,250 in 2017; broadly stable)
• Wales: 738 active (vs roughly 720 in 2017; broadly stable)
• Northern Ireland: 514 active (vs roughly 525 in 2017; broadly stable)
• UK total: 13,043 active (vs roughly 14,250 in 2017)

England absorbed nearly the entire net contraction. The three smaller networks held broadly steady because they operate under different contracts with tighter health-board-level control over openings and closures. We expanded on the full four-nation snapshot in our companion piece, State of UK Community Pharmacy 2026.

Why pharmacies have closed

Five drivers, broadly in order of size of impact.

The drivers in detail

The same five drivers, in narrative form.

1. NHS contract value erosion

The English community pharmacy global sum has been functionally frozen in cash terms since 2019. CPE has repeatedly reported the cumulative real-terms cut at around 30 per cent over a decade, factoring in inflation, energy and wage costs. The 2024 CPE pressures survey found that around three in five English community pharmacies were operating at a loss or close to break-even on NHS work.

2. Margin compression on generic dispensing

Generic medicines make up roughly four in five dispensed items. Reimbursement for generics is set by the NHS Drug Tariff and lags the wholesale price. During the 2022 to 2023 supply-side disruption, pharmacies were repeatedly dispensing items at a per-pack loss, with the NHS reimbursement catching up only weeks or months later via concessionary pricing. The Pharmaceutical Journal covered the consequent cash-flow crisis extensively in 2023 to 2024.

3. Chain restructuring

The most visible cause:

• Lloyds Pharmacy. Lloyds was owned by German wholesaler Celesio from 1997, then by US pharmaceutical distributor McKesson Corporation from December 2014 when McKesson acquired Celesio. McKesson sold its UK business (including Lloyds, AAH Pharmaceuticals and John Bell & Croyden) to pan-European private equity firm Aurelius Group for £477m, with the deal closing on 7 April 2022 (see Chemist+Druggist coverage). Walgreens Boots Alliance was never involved with the Lloyds estate. On 15 January 2023 Lloyds announced the closure of all 237 in-Sainsbury’s pharmacies, and progressively sold or closed its remaining estate to operators including Allied Pharmacies, Cohens and Jhoots through 2023 and 2024. Lloyds Pharmacy as a UK brand is effectively dissolved.
• Boots. Parent Walgreens Boots Alliance announced strategic closures in 2023 totalling roughly 300 UK branches over four years, concentrated in low-footfall locations and smaller towns. Boots remains the largest single chain in the UK with around 1,800 branches as of 2026.
• Smaller chains and acquisitions. Cohens, Day Lewis, Rowlands and Jhoots have all consolidated through M&A over the same period, sometimes absorbing former Lloyds branches and sometimes shedding under-performing ones.

4. Independent succession crisis

Roughly four in ten UK community pharmacies are independents or small multiples. A significant proportion of those owners are over 60 and approaching retirement. The goodwill value of a single-pharmacy NHS contract has fallen sharply in real terms; younger pharmacists prefer the predictability of salaried locum or chain employment over the regulatory and financial burden of single-branch ownership. Many independents are closing not because the business is failing but because no buyer will take it on at the asking price.

5. Rising costs

Energy costs spiked during 2022 to 2023 and have only partly retraced. Locum pharmacist rates rose from around £25 per hour pre-pandemic to widely reported £35 to £45 per hour in 2024 and 2025 (Pharmacist Cooperative data). Rent, business rates and regulatory compliance (GDPR, Falsified Medicines Directive, Hub and Spoke regulation changes) have all added non-trivial fixed costs.

The geographic pattern

Closures have been geographically uneven. Urban centres are mostly stable and in some cases growing as chain reshuffling rebalances estates. Rural areas, particularly those served by single-pharmacy independents, have been hit hardest.

Persistent rural pharmacy deserts cluster in the same UK postcode areas they have for decades: the Outer Hebrides (HS), Shetland (ZE), the Highlands (IV) and mid-Wales (LD). Our detailed pharmacy deserts piece covers the methodology and lists the verified deserts. The contraction story does not change that picture, but it does mean that the previously thin rural networks have got thinner.

Bank-holiday cover is the most visible end-user consequence. In dense urban areas (you can browse our city pages, e.g. London or Manchester), there is usually at least one pharmacy on the bank-holiday rota within a few miles of any address. In rural areas the rota may rely on a single pharmacy covering a 30-mile radius, and if that pharmacy closes permanently, the rota gap is hard to backfill.

What it means for patients

• Travel times have increased for millions of UK residentssince 2017, most acutely in rural and small-town locations.
• Out-of-hours cover is thinner. The 100-hour pharmacy contract route that powered late-night cover from 2005 onwards was closed to new entrants in 2012 and the existing 100-hour cohort is gradually attriting. We cover the historical context in 100-Hour Pharmacies Explained.
• Independents are disproportionately affected, which has knock-on effects on minority-language services, cultural fit, extended-hours cover, and the kind of personalised long-term relationship that big-chain branches struggle to replicate.
• Pharmacy First (England) was launched in January 2024 partly to make the community pharmacy contract more financially viable via per-consultation payments. Early CPE consultation-volume data suggests uptake has been slower than NHS England forecast, although it is rising. The headline contraction trend has not yet visibly reversed.

What is being done about it

• 2024 to 2028 English Community Pharmacy Contractual Framework introduced Pharmacy First, expanded vaccination commissioning, reduced some bureaucracy, and added payments for some clinical services. Verdict roughly 18 months in: mixed. Useful at the margin, not sufficient to reverse the contraction.
• NHS Pharmacy First Scotland has operated since 2020 and is widely regarded as the most integrated community pharmacy minor-illness service in the UK. Scotland’s flat pharmacy count over the same period suggests the contract structure is doing some of its job.
• Welsh Common Ailments Service launched in 2013 and has expanded multiple times. The Welsh network has remained broadly stable under tighter Local Health Board control of new openings and closures.
• Pharmacy First NI launched in November 2021 and has expanded its covered conditions since. The Northern Ireland network has the highest patient-satisfaction signal in our data (Google review median 4.5) and an independent-dominated structure that is less exposed to chain restructuring.
• The Hub and Spoke amendment (UK-wide, effective October 2025) allows pharmacies to share dispensing operations with hub partners. Early days, but potentially significant for the cost base of smaller independents who can outsource the high-volume repeat dispensing work and focus their physical premises on consultations and walk-in advice.

What is coming

The 2026 to 2028 contractual framework negotiations between Community Pharmacy England and NHS England are underway as this article goes to press. The single biggest question is whether the cash envelope will increase in real terms, or whether the contraction trend will continue. CPE has publicly forecast that around 30 per cent of independents are at risk of closure without meaningful contract reform.

In Scotland, Wales and Northern Ireland the picture is less acute but not stable indefinitely. All three devolved governments are watching the English situation closely; any large-scale English closure wave will put political pressure on the devolved settlements as well.

What it means for the future of community pharmacy

The base case for 2027 to 2030 is a continued shift toward fewer-but-larger pharmacies. Chain branches in mid-density catchments, hub-and-spoke-supported independents with strong consultation revenue, and online dispensers will all grow share. Single-branch independents in low-throughput rural locations will continue to close at the rate of 100 to 200 per year unless contract reform materially improves the unit economics.

The 24-hour community pharmacy ideal, already rare in 2026, gets rarer. We have zero verified true 24-hour pharmacies in our directory. The 100-hour contract route that powered late-night cover from 2005 to 2012 is closed to new entrants and will not reopen. Late-night cover increasingly depends on a small number of designated rota pharmacies plus NHS 111 as the urgent-medication backstop.

On the upside, the role of community pharmacy is expanding. Pharmacist independent prescribing is now a foundation-year competency for the 2026 UK pharmacy graduate cohort, opening the door to clinical service commissioning beyond Pharmacy First. Vaccinations, weight management and (in some pilots) NHS hypertension management have all moved into the community pharmacy estate. The pharmacies that survive the contraction are likely to look more clinical and less retail-counter than the 2017 equivalent.

Frequently asked questions